Sarah Bhagat

Sarah Bhagat

Director/Board Member at INOZYME PHARMA, INC.

Net worth: - $ as of 2024-04-29

38 year
Health Technology
Consumer Services
Finance

Profile

Sarah Bhagat is an Independent Director and Board Member at Inozyme Pharma, Inc. and Aeovian Pharmaceuticals, Inc. respectively.
She is also the Chairperson at Atsena Therapeutics, Inc. Dr. Bhagat was previously a General Partner at Sofinnova Investments, Inc. from 2017 to 2022.
She holds a doctorate degree from Yale University and an undergraduate degree from Franklin & Marshall College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-21 0 ( -.--% ) - $ 2024-04-29

Sarah Bhagat active positions

CompaniesPositionStart
INOZYME PHARMA, INC. Director/Board Member 2019-02-28
Chairman 2020-11-30
Director/Board Member 2019-08-31
All active positions of Sarah Bhagat

Former positions of Sarah Bhagat

CompaniesPositionEnd
Private Equity Analyst 2022-07-31
See the detail of Sarah Bhagat's experience

Training of Sarah Bhagat

Franklin & Marshall College Undergraduate Degree
Yale University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sarah Bhagat's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
INOZYME PHARMA, INC.

Health Technology

Private companies3

Finance

Health Technology

Health Technology

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW